In This Article:
The upcoming report from DexCom (DXCM) is expected to reveal quarterly earnings of $0.33 per share, indicating an increase of 3.1% compared to the year-ago period. Analysts forecast revenues of $1.02 billion, representing an increase of 10.3% year over year.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
With that in mind, let's delve into the average projections of some DexCom metrics that are commonly tracked and projected by analysts on Wall Street.
The consensus estimate for 'Revenue- Hardware' stands at $38.39 million. The estimate points to a change of -42.4% from the year-ago quarter.
The average prediction of analysts places 'Revenue- Sensor and other' at $978.78 million. The estimate indicates a year-over-year change of +14.6%.
Analysts predict that the 'Revenue- United States' will reach $709.42 million. The estimate points to a change of +8.6% from the year-ago quarter.
Analysts expect 'Revenue- International' to come in at $303.93 million. The estimate points to a change of +13.5% from the year-ago quarter.
View all Key Company Metrics for DexCom here>>>
Over the past month, shares of DexCom have returned +4.2% versus the Zacks S&P 500 composite's -0.8% change. Currently, DXCM carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DexCom, Inc. (DXCM) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).